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Forecasted trends in vaccination coverage and correlations 
with socioeconomic factors: a global time-series analysis 
over 30 years
Alexandre de Figueiredo, Iain G Johnston, David M D Smith, Sumeet Agarwal, Heidi J Larson*, Nick S Jones*
Summary
Background Incomplete immunisation coverage causes preventable illness and death in both developing and developed 
countries. Identiﬁ cation of factors that might modulate coverage could inform eﬀ ective immunisation programmes 
and policies. We constructed a performance indicator that could quantitatively approximate measures of the susceptibility 
of immunisation programmes to coverage losses, with an aim to identify correlations between trends in vaccine 
coverage and socioeconomic factors. 
Methods We undertook a data-driven time-series analysis to examine trends in coverage of diphtheria, tetanus, and 
pertussis (DTP) vaccination across 190 countries over the past 30 years. We grouped countries into six world regions 
according to WHO classiﬁ cations. We used Gaussian process regression to forecast future coverage rates and provide 
a vaccine performance index: a summary measure of the strength of immunisation coverage in a country.
Findings Overall vaccine coverage increased in all six world regions between 1980 and 2010, with variation in volatility 
and trends. Our vaccine performance index identiﬁ ed that 53 countries had more than a 50% chance of missing the 
Global Vaccine Action Plan (GVAP) target of 90% worldwide coverage with three doses of DTP (DTP3) by 2015. These 
countries were mostly in sub-Saharan Africa and south Asia, but Austria and Ukraine also featured. Factors associated 
with DTP3 immunisation coverage varied by world region: personal income (Spearman’s ρ=0·66, p=0·0011) and 
government health spending (0·66, p<0·0001) were informative of immunisation coverage in the Eastern 
Mediterranean between 1980 and 2010, whereas primary school completion was informative of coverage in Africa 
(0·56, p<0·0001) over the same period. The proportion of births attended by skilled health staﬀ  correlated signiﬁ cantly 
with immunisation coverage across many world regions.
Interpretation Our vaccine performance index highlighted countries at risk of failing to achieve the GVAP target of 
90% coverage by 2015, and could aid policy makers’ assessments of the strength and resilience of immunisation 
programmes. Weakening correlations with socioeconomic factors show a need to tackle vaccine conﬁ dence, whereas 
strengthening correlations point to clear factors to address.
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Introduction
Rates of vaccine-preventable diseases have decreased in 
many parts of the world in the past few decades, but 
many children remain unvaccinated. In 2013, UNICEF 
reported that 21·8 million children younger than 1 year 
had not completed the diphtheria, tetanus, and pertussis 
(DTP) immunisation series, with a similar number not 
receiving a single measles vaccination.1 Although access 
to vaccinations is the main barrier in many settings, 
growing numbers of parents do not immunise their 
children based on their own personal attitudes.2,3
Both socioeconomic and attitudinal barriers to vaccination 
coverage have been identiﬁ ed in several countries. A set of 
recurring socioeconomic and demographic correlates of 
coverage have been reported, with parental education 
level,4–8 age,6,9,10 employment status and workplace,4,6,7 
religion,11 ethnic origin,12 gender of the child,13 poverty,14–18 
and distance to health-care facilities4,6,11,14,17,18 all linked to 
vaccine uptake, although marked diﬀ erences often exist 
between countries.11 Repeating themes have likewise been 
identiﬁ ed in examination of personal reasons for vaccine 
acceptance or delay, which range from perceived risks about 
potential adverse events, to religious or political beliefs that 
are external to, albeit inﬂ uential in, vaccination.9,19–27 Trust in 
health-care professionals19,20,23,24 and the government19,23,26 also 
features highly.
Recommendations to address gaps in vaccine 
coverage are context dependent. Targeting of mothers 
with low education,28 low health literacy,29 and 
dissemination of more information to communicate 
vaccine beneﬁ ts and risks transparently2 have been 
suggested to aid in improvement of vaccine hesitancy, 
as has the customisation of messages and engagement 
eﬀ orts for speciﬁ c groups.30 Eﬃ  cient identiﬁ cation of 
clusters of non-vaccinators through monitoring of local 
immunisation rates has been identiﬁ ed as a key public 
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health challenge for the prevention of outbreaks when 
local groups adopt a non-vaccination status (as was the 
case in the 2014–15 measles outbreak at Disneyland, 
Anaheim, CA, USA).31 Monitoring of trust in 
immunisation programmes through various indices 
has also been proposed as a way to better understand 
the circumstances in which vaccine hesitancy might 
arise.32,33
To build on the current literature, we constructed a 
vaccine performance index: a summary measure of the 
strength of immunisation coverage in a country. This 
index could be used to describe the variability in vaccine 
coverage induced by conﬁ dence and access issues, 
allowing for an intercountry analysis of trends. We 
interpreted the coverage values in view of the Global 
Vaccine Action Plan (GVAP)’s target of attaining 
90% vaccination coverage in all countries by 2015.34 We 
discuss the implications of both the correlative study 
and the performance index on immunisation strategies. 
We undertook a large-scale, worldwide correlative 
analysis to investigate the association between a range 
of socioeconomic factors and vaccine coverage, and to 
identify temporal trends and diﬀ erences between WHO 
world regions. 
Methods
Data
We examined a broad range of quantitative data for 
190 descriptive socioeconomic factors for 190 countries 
from 1980 to 2010. Factors spanned economics, 
health care, industry, demographics, communications, 
infrastructure, physical geography, trade, and education. 
This breadth of socioeconomic factors was used to 
expose, in an unbiased way, which indicators might be 
related to immunisation coverage. Countries were 
grouped into six world regions according to WHO 
classiﬁ cations: Africa, the Americas, the Eastern 
Mediterranean, Europe, South-East Asia, and the 
Western Paciﬁ c.35 We obtained data from the Gapminder 
website, which draws from sources including the World 
Bank, the International Labour Organization, and WHO. 
A data curation approach was used to ﬁ lter and impute 
missing data (appendix).
Data for vaccine coverage (the proportion of a target group 
immunised) were obtained for BCG tuberculosis vaccine, 
DTP1 and DTP3 (representing the ﬁ rst and third doses, 
respectively, and typically scheduled for 6 months after 
birth), measles-containing vaccine (MCV), and polio 
(POL3, representing the third dose of the polio vaccination 
Research in context
Evidence before this study
We searched Google Scholar between Jan 1, 1980, and  
Jan 1, 2016, for studies assessing socioeconomic correlates of 
vaccine coverage. Our search terms included the words 
“socio-economic”, “demographic”, “correlates”, and “vaccine 
coverage”, with variations in each individual term allowed. 
For example, “vaccine” could be with “vaccination” or “immunise” 
with “immunisation”, in addition to speciﬁ c names of 
vaccine-preventable diseases such as “DTP” and “MMR”; 
alternative spellings, such as “immunize”, were also allowed. 
For attitudinal correlates of vaccine coverage, we used search 
terms such as “vaccine hesitancy”, “vaccine acceptance”, and 
“vaccine delay”. We identiﬁ ed few publications that examined 
diﬀ erences in both attitudinal and socioeconomic correlates 
between countries, although we found some recent reviews that 
assessed diﬀ ering attitudes towards vaccination uptake across 
Europe, and diﬀ ering socioeconomic correlates in east African 
countries. Both attitudinal and socioeconomic surveys reported 
various correlates of vaccine uptake. Attitudes range from 
personal, religious, and political beliefs, to trust in health care and 
the government. Socioeconomic correlates vary between 
countries, but education level, religion, ethnic origin, and distance 
to health-care facilities are all recurring themes.
Added value of this study
We studied correlations between 190 socioeconomic factors 
and immunisation coverage in 190 countries, and report 
variations in the strength of socioeconomic correlates between 
world regions and across time. To our knowledge, this work 
represents the broadest analysis of socioeconomic links to 
vaccine coverage yet available, allowing insights into how 
socioeconomic correlates modulate coverage and how these 
correlates vary by world region. Forecasting of vaccine coverage 
time series enabled us to summarise the recent trend and 
variability in uptake rates and construct a vaccine performance 
index, which is, as far as we know, the ﬁ rst quantitatively 
derived marker of vaccine performance. Our predictive 
performance index represents a distinctive, interpretable 
measure to assess likely future vaccine coverage behaviour and 
resilience of immunisation programmes to volatile changes 
triggered by external shocks, whether driven by political 
rumour or natural disaster.
Implications of all the available evidence
By use of a probabilistic forecast of future vaccination levels, 
we have provided a world map of a vaccine performance 
index that is informative of both the likelihood of stagnated 
or substandard coverage levels and the chance coverage levels 
will decline. These forecasts can easily identify countries that 
are likely to fail to achieve the Global Vaccine Action Plan 
target of 90% coverage of diphtheria, tetanus, and pertussis 
vaccine by 2015. We speculate that regions with strong 
socioeconomic ties to vaccination coverage can be 
interpreted as targets for intervention (because 
socioeconomic factors present barriers to vaccination), but 
that some regions (namely, Europe and the Americas), with 
low ties to socioeconomic factors, have increased attitudinal 
barriers to vaccination. 
See Online for appendix
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programme) from the 2011 WHO–UNICEF estimates of 
vaccine coverage36 for the same countries and across the 
same time period, although we used the latest estimates in 
our vaccine performance index. Immunisation rates have 
increased across all WHO regions in the past three decades: 
coverage is highest in Europe and the Americas, with other 
regions achieving less complete coverage (ﬁ gure 1A). Joint 
investigation of all vaccine time series showed that strong 
mutual correlations exist between the DTP1, DTP3, MCV, 
and POL3 vaccines, but that BCG falls outside this grouping 
(ﬁ gure 1B). Time series of DTP3 coverage in individual 
countries diﬀ er substantially in magnitude, variability, and 
trends (ﬁ gure 1C). We henceforth focused on DTP3 
coverage because of this high correlation and in accordance 
with previous literature in which DTP3 is regarded a 
marker of the strength of a country’s immunisation 
programmes (because the vaccine requires three diﬀ erent 
administrations).37 A correlative analysis of the other 
vaccines is presented in the appendix.
We illustrate time-series data for socioeconomic factors 
with two examples: female education (ﬁ gure 1D) and rural 
access to water (ﬁ gure 1E). Figure 1F shows an example 
scatter plot of average DTP3 coverage against female 
education levels for three regions. We further explored the 
dataset by use of t-distributed stochastic neighbour 
embedding (t-SNE), which is a local structure-preserving 
clustering technique that can improve visualisation quality 
of high-dimensional data over other clustering 
algorithms.38 We used t-SNE for visualisation of a 
similarity matrix, constructed by taking correlations 
across all countries between all pairs of socioeconomic 
factors and vaccines in a single year (xit [ for socioeconomic 
factor or vaccine i in year t]) and averaging the correlation 
across all 31 years:
where Sij are elements of the similarity matrix S, T is 
the total number of years, and ρ is the Spearman’s rank 
correlation between two socioeconomic factors (or 
vaccines). Application of t-SNE showed strong links 
between socioeconomic factors in similar categories and 
revealed a separation of the BCG vaccine, which is closer 
in t-SNE space to factors relating to health spending, 
from the other four vaccines, which seem to be more 
correlated with schooling variables (ﬁ gure 1G).
Correlative analysis
We used Spearman’s rank correlation to explore links 
between coverage and socioeconomic factors (ﬁ gure 1F) 
because coverage data are conﬁ ned to the 0–100 interval 
and often non-linear relations arise between coverage 
and socioeconomic factors (which might be ordinal). To 
investigate the strengths of correlations with coverage 
over time, we computed a time-averaged correlation 
between each factor (xt) and coverage (yt) in a given year 
(t) for all countries in a particular region ρ(xt, yt), and we 
dropped the index i referring to socioeconomic indicator; 
we then took the time-average of this value:
where t1 is the most distant year and t2 is the most 
recent year. For historic trends, we considered 1980 as t1 
and 2010 as t2 and, for recent trends, we considered 2001 
as t1. To focus on the strongest signals, we agglomerated 
the top-ten correlating socioeconomic factors in each 
region across both time ranges for a cross comparison 
of informative correlates between regions; we 
restricted these socioeconomic factors to those with a 
Bonferroni-corrected meta p value (against the null 
hypothesis that the set of correlations were uninformative) 
of less than 0·01. In addition to these socioeconomic 
factors, we included other factors that are related and 
useful for comparison: primary school completion rate 
(male), improved sanitation access (overall and rural), 
and improved urban water access (appendix).
Forecasting
We ﬁ rst logit-transformed vaccine coverage data:
where y’ is transformed vaccine coverage and y is raw 
coverage, to map the coverage values to the real line, so 
that Gaussian distributions over datapoints were not 
truncated at values of 0 or 100. We used Gaussian 
processes, with a squared exponential covariance 
function and linear mean function (to account for the 
broadly linear increases in trend in this transformed 
space), to forecast vaccine coverage data, based on 
previous coverage values. The appendix summarises the 
prediction accuracy of this method, which is quantiﬁ ed 
by forecasting on a test dataset. We used the predictive 
distribution over forecasted values to deﬁ ne a summary 
measure—the vaccine performance index—which 
balances the (desirable) probability of attainment of high 
future coverage against the (undesirable) probability of 
experiencing a future negative perturbation to coverage, 
informed by preceding trends and variability. We deﬁ ned 
the vaccine performance index as the probability of 
achieving of coverage in excess of a threshold value (v), 
less the probability of a drop in coverage of size at least d: 
where VPI is the value of the vaccine performance index 
at time t*, tN is the most recent point for which coverage 
exists, and t*=tN+τ is the forecasted point (so that, for 
example, tN=1999 and t*=2000 for a country’s 2000 vaccine 
Sij = 1 Σtρ(xit,xjt)|
1
T
|–
= Σt= t₁ ρ(xt,yt)t2     t1+1
1ρ t ₂
y'= log(         1)100y
VPIv,  d (t*)=P[y (t*)> v]–P [y (t*)< y(tN)–d]   τ ,    
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Figure 1: Dynamics of socioeconomic factors and DTP3 coverage
(A) Increasing trends in vaccine coverage across WHO regions with time (1980–2010). Leftmost circles represent 1980 coverage rates and rightmost circles represent 
2010 rates, averaged across all countries in a region. (B) Spearman correlation between all vaccines across all countries and years. (C) Diversity of behaviours in DTP3 
coverage with time. (D) Time series of female education. (E) Time series of rural access to water. (F) Scatter plot showing the link between DTP3 coverage and female 
education in 1982. (G) Visualisation of similarity matrix between all pairs of socioeconomic factors by use of t-distributed stochastic neighbour embedding (t-SNE). 
Heuristic categories were assigned before t-SNE was applied. DTP1=diphtheria, tetanus, and pertussis ﬁ rst dose. DTP3=diphtheria, tetanus, and pertussis third dose. 
MCV=measles-containing vaccine. POL3=polio vaccine third dose. AFR=Africa. AMR=Americas. EMR=Eastern Mediterranean. EUR=Europe. SEAR=South-East Asia 
Region. WPR=Western Paciﬁ c region. HDI=Human Development Index.
Articles
www.thelancet.com/lancetgh   Vol 4   October 2016 e730
A
2001 2005
2009 2013
–1 0
VPI (v=95, τ=1, d=2)
+1
20
40
60
80
100
DT
P3
 co
ve
ra
ge
 (%
)
B Malta Zimbabwe Cambodia UK Algeria
1995 2000 2005 2010
20
40
60
80
100
DT
P3
 co
ve
ra
ge
 (%
)
Year 
C Latvia
1995 2000 2005 2010
Year 
San Marino
1995 2000 2005 2010
Year 
Cape Verde
1995 2000 2005 2010
Year 
Estonia
1995 2000 2005 2010
Year 
Romania
Figure 2: VPI values
(A) Sub-Saharan Africa, parts of southern and South-East Asia, and some European countries have low VPI. White areas signify missing data. (B) Countries with the largest improvement in VPI 
between 2009 and 2013 (Malta is most improved). (C) Countries with the largest decrease in VPI between 2009 and 2013 (Romania has the most deteriorated performance). WHO–UNICEF coverage 
estimates are in blue with the observed (test) value in 2013 in red; the mean of the Gaussian process in shown in black and shaded areas represent 95% CIs for training (blue) and forecasted (red) 
data. The red vertical line indicates 2013. DTP3=diphtheria, tetanus, and pertussis third dose. VPI=vaccine performance index.
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performance index value) and for which we mapped the 
predictive distributions back to the range 0–100. This 
expression is reweightable if the reader or policy maker 
wishes to focus on a diﬀ erent combination of strategic 
properties. There are natural alternative forms to this index; 
for example, to assess the GVAP goal of 90% coverage in all 
countries by 2015, we set τ equal to 2 years, v equal to 90, 
and d equal to inﬁ nity, thus using our model to forecast the 
probability that coverage in 2015 will exceed 90%. We used 
MATLAB (version 2015a) for all analyses.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding authors had full access to all 
the data in the study and had ﬁ nal responsibility for the 
decision to submit for publication.
Results
We assessed countries’ trends and variability by 
considering the probability of coverage exceeding 
95% minus the probability of coverage falling by more 
than 2% 1 year in the future (ie, v=95, τ=1, and d=2); the 
appendix details the justiﬁ cation for these parameter 
values and alternative forms of this index, which 
might be natural alternatives that address diﬀ erent 
policy-making goals. Figure 2A shows worldwide vaccine 
performance index values for these parameters in 2001, 
2005, 2009, and 2013. DTP3 coverage time series and 
Gaussian process ﬁ ts for the ﬁ ve countries with the 
highest increases and decreases in vaccine performance 
index values from 2009 to 2013 are displayed in ﬁ gure 2B 
and 2C, respectively. Malta had the most improved 
vaccine performance index between 2009 and 2013, 
since, in 2009, it had sharply decreasing coverage rates, 
which have since fully recovered (ﬁ gure 2B). Romania 
had the most deteriorated coverage values, since high 
and steady values have gradually worsened (ﬁ gure 2C). 
The appendix presents vaccine performance index values 
for all countries.
Consistently high-performing countries included 
Saudi Arabia, Russia, Hungary, and Slovakia, which have 
had consistently high DTP3 coverage rates since at least 
2000 (appendix). The UK, USA, Canada, Australia, and 
New Zealand had historically lower vaccine performance 
index values, which have improved in the UK, USA, and 
Canada, but remain low in Australia and New Zealand 
(ﬁ gure 2, appendix).
More generally, Europe, North and Central America, 
and much of Asia have shown steady progress since 
2005; by contrast, South America, the Indian 
subcontinent, and sub-Saharan Africa have shown little 
improvement (ﬁ gure 2, appendix). Surprisingly, many 
European countries have struggled to increase coverage 
to top levels: Norway, Iceland, Ukraine, and Romania, 
despite reasonably high DTP3 coverage rates in 2013 
(83%, 91%, 94%, and 89%, respectively) all have vaccine 
performance index values far from +1 (ﬁ gure 2, appendix), 
signifying coverage rates that are below 95%, and show 
little sign of improvement beyond this threshold. 
Findings for Africa are mixed: north African countries 
have high vaccine performance index values, whereas 
countries in sub-Saharan Africa generally have low 
values due to high variability and low coverage, with 
some exceptions, notably Rwanda, Burundi, Botswana, 
and Zimbabwe (ﬁ gure 2, appendix). These low and 
volatile coverage rates are likely to be a sign of the vast 
number of people in sub-Saharan Africa with poor 
continued access to latter doses in the DTP programme.
South-East Asia generally performs poorly; many 
countries have vaccine performance values close to 
–1 (ﬁ gure 2, appendix), suggesting that chances of a 
decline in coverage in the following year are high. Many 
Eastern Mediterranean countries have shown clear 
improvement in the past decade, with countries typically 
presenting high, sustained coverage rates, although 
Syria, Iraq, Pakistan, Afghanistan, and Yemen are 
notable exceptions (ﬁ gure 2, appendix).
To assess the GVAP goal of 90% coverage in all 
countries by 2015, we used our vaccine performance 
index to forecast the probability that coverage in 2015 
(2 years after the most recent available datapoints, in 
2013) will exceed 90%. This analysis yielded a bimodal 
distribution (ﬁ gure 3), whereby countries will either 
comfortably reach this goal or fall rather short of it (with 
the exception of South America, which has many 
borderline countries). European countries generally 
perform better than other regions (with the notable 
exceptions of Denmark, Iceland, Romania, Austria, 
Moldova, San Marino, and Ukraine), with an almost 
certain chance of reaching the GVAP goal (on the basis 
of their recent trend; ﬁ gure 3). Countries in 
sub-Saharan Africa and the Indian subcontinent 
(with only few exceptions) seem likely to drastically miss 
the GVAP target (ﬁ gure 3). This inference and forecasting 
approach highlights not only regions that require 
stronger action, but also borderline countries where 
comparatively minor action might realise the GVAP goal.
From the broad range of 190 socioeconomic factors 
investigated, those shown in ﬁ gure 4A can be interpreted 
as the most likely to have a genuine (and consistent) link 
with DTP3 coverage over time. The strength of correlation 
between socioeconomic factors and DTP3 coverage varies 
between region, over time, and across socioeconomic 
factors (ﬁ gure 4A). Births attended by skilled health staﬀ  
and access to sanitation are the two factors that have 
mean-averaged p values of less than 0·05 across the 
largest number of regions (ﬁ gure 4A). In Africa, the 
Americas, and Europe, the magnitude of correlations are 
high historically, but have decreased recently, and display 
patterns that are broadly similar: the importance of access 
to water and sanitation, births attended by skilled health 
staﬀ , and economic factors in determining coverage is 
historically high, but diminishing (particularly in the 
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Americas; ﬁ gure 4A). An exception to this ﬁ nding is the 
correlation with the service industry (the service 
socioeconomic factor is the net output of the service 
industry, deﬁ ned as wholesale and retail trade, transport, 
and other governmental services such as education and 
health care39), which is reasonably high and increasing in 
Africa and the Americas. By contrast, in the Eastern 
Mediterranean and the Western Paciﬁ c region, 
socioeconomic factors have remained correlated over time 
(ﬁ gure 4A). The South-East Asia region has a more mixed 
pattern of recent changes in socioeconomic connections 
with, for example, a decreasing link to rates of primary 
school completion and an increasing link to water access 
and sanitation (ﬁ gure 4A).
In both Africa and the Eastern Mediterranean, 
educational variables and access to water are particularly 
informative about DTP3 coverage, whilst in the Eastern 
Mediterranean alone, government health spending, 
income metrics, access to sanitation, phone use, and CO2 
emissions are strongly linked with coverage (ﬁ gure 4A). 
Socioeconomic correlates are generally low (both recently 
and historically) in Europe, and are reasonably low in the 
Americas (ﬁ gure 4A). In South-East Asia, education ratio 
and access to water are notably high correlates that have 
not decreased in importance (ﬁ gure 4A). In the Western 
Paciﬁ c region, births attended by skilled health staﬀ  is the 
strongest correlate (and one that appears to be becoming 
more informative of DTP3 coverage; ﬁ gure 4A).
The association between public health spending and 
coverage varies globally, with a strong link in the Eastern 
Mediterranean and weaker links in South-East Asia, 
Africa, and the Western Paciﬁ c (where the link is 
increasing), and the Americas (where it is decreasing; 
ﬁ gure 4A). Only in the Eastern Mediterranean is gross 
domestic product per capita the strongest correlate of 
vaccine coverage; in all other regions the strongest links 
are with less directly economic factors (ﬁ gure 4A).
We noted a signiﬁ cant diﬀ erence in the correlation 
strength between DTP3 coverage and male and female 
education in Africa and South-East Asia (ﬁ gure 4B; 
p value from paired t tests <0·0001 for both); correlations 
were not signiﬁ cant for the other regions at the p=0·05 
level, but paternal education was more informative in 
the Western Paciﬁ c.
We plotted these correlations for the other vaccinations 
we examined; some notable observations arose from the 
comparison of these other vaccines with DTP3 (appendix). 
One regional trend was that the eﬀ ect of public health 
spending and access to sanitation in South-East Asia, 
which was moderate for DTP3, was very high and often 
increasing for other vaccines. Another observation was 
that the Eastern Mediterranean, where we recorded stable 
or decreasing correlations with several socioeconomic 
factors for DTP3, instead showed increasing links with all 
factors (except investments) for BCG. The Americas, 
which had decreasing correlations for most factors with 
DTP3, showed decreases to almost Europe-like absences 
of coverage correlation in DTP1 and MCV, although all 
other regions and factors had similar patterns for DTP3 
and MCV coverage. Europe is broadly the same across all 
vaccines except BCG, for which correlations seem to be 
negative between factors such as government health 
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Figure 3: Extrapolation of current coverage trends based on the Gaussian process model
(A) 53 countries have more than a 50% chance of failing to meet Global Vaccine Action Plan 2015 targets if current diphtheria, tetanus, and pertussis (DTP3) coverage 
trends continue. 0·5 ≤ VPI < 0·9: Angola, Argentina, Armenia, Australia, Bosnia and Herzegovina, Brunei Darussalam, Burkina Faso, Cameroon, Chile, Colombia, Costa 
Rica, Cuba, Denmark, El Salvador, Honduras, Iceland, Jamaica, Kiribati, Malawi, Nauru, Nepal, Norway, Palau, Paraguay, Peru, Romania, Samoa, Senegal, Trinidad and 
Tobago, Tuvalu, Tanzania, Vietnam, Yemen, Zimbabwe. 0·1 ≤ VPI < 0·5: Barbados, Comoros, Korea, Djibouti, Dominican Republic, Laos, Liberia, Mauritania, 
Micronesia, Namibia, Panama, Moldova, San Marino, Solomon Islands, Suriname, Togo, Ukraine. VPI <0·1: Afghanistan, Austria, Benin, Central African Republic, Chad, 
Congo, Côte d’Ivoire, Democratic Republic of the Congo, Equatorial Guinea, Ethiopia, Gabon, Guinea, Guinea-Bissau, Haiti, India, Indonesia, Iraq, Kenya, Lebanon, 
Madagascar, Mali, Marshall Islands, Mozambique, Burma, Niger, Nigeria, Pakistan, Papua New Guinea, Somalia, South Africa, Syria, Timor-Leste, Uganda, Vanuatu, 
Venezuela, Zambia. VPI=vaccine performance index. (B) Histogram of index values.
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spending, sanitation access, income, and BCG coverage. 
All estimated correlations in the study were robust to our 
imputation procedure (appendix).
Discussion
In keeping with ﬁ ndings from previous studies, our 
study found several socioeconomic factors to be 
informative of immunisation levels, such as correlates 
related to health-care facilities3 and educational 
variables.4–8 Literature from the past few years has indeed 
identiﬁ ed various socioeconomic and attitudinal barriers 
to vaccination coverage for a number of countries, such 
as parental education level,4–8 age,6,9,10 employment status 
and workplace,4,6,7 poverty,14–18 inequity,40 and distance to 
health-care facilities.4,6,11,14,17,18 Findings from a systematic 
review41 emphasised the link between out-of-hospital 
birth and reduced immunisation rates in countries with 
medium or low Human Development Index (HDI) 
scores, and associated the use of private health-care 
services and no health insurance with low immunisation 
levels in countries with very high HDI scores. We 
likewise found a link between income and births 
attended by skilled health staﬀ  and immunisation levels. 
We believe we are the ﬁ rst to identify several other 
potential barriers to immunisation coverage; for example, 
the link between governmental health spending and 
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Figure 4: Historic and recent socioeconomic correlates with DTP3 coverage 
(A) Groups of key socioeconomic factors, obtained by collecting the top correlating factors in each region across the time periods 1980–2010 and 2001–10. Only factors with the most consistent 
non-zero correlations with coverage are presented. Spearman’s rho is represented by thick dark bars for 1980–2010, and by thin light bars for 2001–10. Mean p values are shown in black for 
1980–2010 and in red for 2001–10: *** denotes p<0·001 , ** denotes p<0·01, * denotes p<0·05, and ◊ denotes p<0·10. Error bars represent 95% CIs. (B) Time series of the Spearman’s ρ between 
DTP3 coverage and female (blue) and male (red) education. GDP=gross domestic product. GNI=gross national income. AFR=Africa. AMR=Americas. EMR=Eastern Mediterranean. EUR=Europe. 
SEAR=South-East Asia Region. WPR=Western Paciﬁ c region. DTP3=diphtheria, tetanus, and pertussis third dose.
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primary school completion rates (in addition to income) 
across Eastern Mediterranean countries, and access to 
water and primary school completion rates in Africa.
We suggest that having a set of low-magnitude 
socioeconomic correlations with vaccine coverage 
corresponds to an encouraging state wherein vaccine 
access is available to most of the population. Conversely, 
when strong socioeconomic correlations exist, they signal 
potential limiting factors in vaccine access, although 
further analyses would be needed to infer causation 
between these factors and coverage. Hence, Europe, which 
has displayed consistently low socioeconomic correlations, 
enjoys high access to all vaccines; however, it suﬀ ers from 
non-infrastructural barriers to vaccination that centre on 
religious or philosophical beliefs and perceived risks rather 
than access, which we suspect is by contrast with other 
regions in which access is the main barrier.3,42 Notably, the 
Americas has shown low (and decreasing) socioeconomic 
correlations with DTP1, MCV, and BCG, but higher 
correlations (although currently decreasing) associated 
with DTP3. This pattern suggests a transitional stage 
wherein vaccines in the region are broadly accessible, but 
that some factors (including attendance of medical staﬀ  at 
births) are restricting uptake of DTP3. This notion seems 
to be supported in the literature, which cites a range of 
socioeconomic determinants (including refusal from 
groups with higher socioeconomic status,43,44 personal 
beliefs, and low access to health-care facilities) as barriers 
to vaccination.3 We note the strength and consistency of 
births attended by skilled health staﬀ  as an informer of 
DTP3 coverage rates, and highlight the potential of this 
factor for use as a proxy indicator of the condition of a 
health-care system.
We speculate that regions where correlations are 
strengthening can be interpreted as more pressing 
targets for intervention. For example, the ratio of girls to 
boys in primary education, public health spending, and 
sanitation in South-East Asia and the Eastern 
Mediterranean; rural access to clean water (which is 
widely believed to be able to prevent polio in some parts 
of Nigeria27) and the presence of skilled health staﬀ  in 
Africa, where a potential surrogate, children born in a 
public or private health-care facility, is consistently linked 
to completion of routine vaccinations.11
Although an aim of the present study was to provide a 
global overview of correlates of immunisation coverage, 
we note several limitations. Regional variability is likely 
to exist within countries and also between other sets of 
countries grouped by regions other than those deﬁ ned by 
the WHO. A large-scale global analysis investigating 
regional trends and identifying factors associated both 
within and between countries could therefore uncover 
more nuanced trends. Higher-frequency data from social 
media sources might be able to predict trends in 
vaccination uptake behaviour more accurately than can 
lower frequency national coverage data. The vaccine 
performance index methodology can be naturally 
integrated with models incorporating high-frequency 
time-series predictive variables to more accurately 
forecast immunisation levels as high-frequency data for 
vaccine sentiments becomes increasingly available. Such 
ﬁ ne-grained analyses could facilitate the use of time lags 
in exploration of predictive models of vaccine coverage 
using combinations of high-frequency social media data 
and low-frequency socioeconomic factors.
Review of historical trends and variability in vaccination 
rates can aid policy makers’ assessments of the strength 
and resilience of immunisation programmes. The 2014 
GVAP report notes that a third of the world’s 194 countries 
were failing to reach 90% coverage in 2013,45 but these 
static summaries conceal both the vaccination track record 
and the possible future immunisation levels. A WHO 
report46 notes that 65 countries had failed to achieve either 
“90% coverage nationally or 80% coverage in every district 
or equivalent administrative unit against diphtheria, 
tetanus and whooping cough by 2015”, which is in line 
with predictions from our vaccine performance index.
We thus present our vaccine performance index as a tool 
for future research, which could enhance GVAP assessment 
reports for future targets by providing predictive measures 
that account for coverage trends and variability.
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